SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales declined to Rs. 42827.00 millions for the December 2025 quarter as compared to Rs. 50150.00 millions during the corresponding quarter last year.The company suffered a huge decline of -89.33% to Rs. 906.00  millions from Rs. 8494.00 millions  of corresponding previous quarter.The company reported a degrowth in operating Profit to 4599.00 millions from 14278.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 42827.00 50150.00 -14.60 167108.00 175525.00 -4.80 231154.00 194838.00 18.64
Other Income 3603.00 2354.00 53.06 11228.00 6608.00 69.92 10034.00 8623.00 16.36
PBIDT 4599.00 14278.00 -67.79 55397.00 65278.00 -15.14 83852.00 67887.00 23.52
Interest 414.00 433.00 -4.39 940.00 788.00 19.29 1099.00 218.00 404.13
PBDT 4185.00 13845.00 -69.77 54457.00 64490.00 -15.56 82753.00 67669.00 22.29
Depreciation 3143.00 2651.00 18.56 8889.00 7749.00 14.71 10394.00 9756.00 6.54
PBT 1042.00 11194.00 -90.69 45568.00 56741.00 -19.69 72359.00 57913.00 24.94
TAX 136.00 2700.00 -94.96 11177.00 15254.00 -26.73 18865.00 14493.00 30.17
Deferred Tax 6.00 137.00 -95.62 853.00 992.00 -14.01 960.00 875.00 9.71
PAT 906.00 8494.00 -89.33 34391.00 41487.00 -17.10 53494.00 43420.00 23.20
Equity 835.00 834.00 0.12 835.00 834.00 0.12 834.00 834.00 0.00
PBIDTM(%) 10.74 28.47 -62.28 33.15 37.19 -10.86 36.28 34.84 4.11

Dr. Reddys Lab Share Price

1220.75 -11.50 (-0.93%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×